Original Research

Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model

Sosne G, Ousler GW

Clinical Ophthalmology 2015, 9:877-884

Published Date: 20 May 2015